1-20 of 782
weight reduction
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition

Neeta Bala Tannan, Mandana T. Manzari, Laurie Herviou, Mariana Da Silva Ferreira, Connor Hagen, Hiroto Kiguchi, Katia Manova-Todorova, Venkatraman Seshan, Elisa de Stanchina, Daniel A. Heller, Anas Younes
Journal: Blood
Blood (2021) 137 (15): 2057–2069.
https://doi.org/10.1182/blood.2020008017
Published: 2021
Includes: Supplemental data
Journal Articles

Functional Assessment of Chronic Illness Therapy-Fatigue Scale (FACIT-Fatigue): Cognitive Debriefing in Patients with Chronic Lymphocytic Leukemia (CLL)

Helena Chung, MA BA, Daniel Eek, PhD, Calvin Krogh, MBA MPH, Matthew Blowfield, MSc, Oren Meyers, PhD, Toby A. Eyre
Journal: Blood
Blood (2019) 134 (Supplement_1): 4777.
https://doi.org/10.1182/blood-2019-122849
Published: 2019
Journal Articles

Clinical Spectrum, Long-Term Outcomes and Predictors of Relapse after Imatinib Discontinuation in FIP1L1-Pdgfra-Associated Chronic Eosinophilic Leukemia: Data from 150 Patients

Julien Rohmer, MD, Matthieu Groh, MD, Julie Trichereau, Kewin Panel, Claude Preudhomme, PharmD, PhD, Fanny Legrand, PhD PharmD, Felix Ackermann, MD, Amélie Couteau-Chardon, MD, Mikael Ebbo, MD PhD, Olivier Fain, MD, Lionel Galicier, MD, Mohamed Hamidou, Mathilde Hunault, MD PhD, Etienne Lengline, MD, Catherine Mohr, MD, Franck E Nicolini, MD PhD, Jerome Rey, Louis Terriou, MD, Chafika Morati Hafsaoui, MD, Suzanne Tavitian, MD, Irene Machelart, Katayoun Jondeau, MD, Bertrand Arnulf, Jean-Christophe Ianotto, MD PhD, Jean-Marc Zini, Viviane Dubruille, MD, Francoise Huguet, MD, Borhane Slama, MD, Fabrice Jardin, Didier Adiko, Elise Toussaint, MD, Aurelien Guffroy, MD PhD, Faustine Lhomme, MD PhD, Nathalie Grardel, Cyrielle Gesquieres, Guillaume Lefèvre, MD PhD, Jean Emmanuel Kahn, PhDMD
Journal: Blood
Blood (2019) 134 (Supplement_1): 840.
https://doi.org/10.1182/blood-2019-130009
Published: 2019
Journal Articles

Addition of the PARP Inhibitor, Talazoparib, to Gemtuzumab Ozogamicin Significantly Enhances Anti-Leukemic Activity in Human CD33+ Acute Myeloid Leukemia

Scott M. Portwood, MBA, MS, Marianna C Cantella, BE, Tara L. Cronin, BA, Eunice S. Wang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1371.
https://doi.org/10.1182/blood-2019-130427
Published: 2019
Journal Articles

A Phase 2 Study of Glasdegib for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with High Risk of Post-Allogeneic Stem Cell Transplantation Relapse

Andrew Kent, MD PhD, Sumithira Vasu, MDMBBS, Derek Schatz, Natalie Monson, Steven Devine, MD, Clayton Smith, MD, Jonathan A Gutman, MD, Daniel A Pollyea, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1311.
https://doi.org/10.1182/blood-2019-127418
Published: 2019
Journal Articles

Impact of Rituximab in the Clinical Outcomes of Hairy Cell Leukemia: A Retrospective Single-Institution Analysis

Kristen Gonter-Aubin, DO, Daniel Alan Kerr, MD PhD, Ashley Rose, MD, Thanh Lana Nguyen, MDBS, Julio C. Chavez, MD, Javier Pinilla Ibarz, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1542.
https://doi.org/10.1182/blood-2019-129028
Published: 2019
Journal Articles

The Combination of CUDC-907 and Gilteritinib Shows Promising Antileukemic Activity in Vitro and In Vivo in Preclinical Models of FLT3-ITD AML

Tristan Knight, MD, Xinan Qiao, BS, Jun Ma, Holly Edwards, BS, Lisa Polin, PhD, Juiwanna Kushner, Sijana H Dzinic, PhD, Kathryn White, Hai Lin, MD, Yue Wang, Jeffrey W. Taub, MD, Yubin Ge, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1262.
https://doi.org/10.1182/blood-2019-123793
Published: 2019
Journal Articles

Poor-Risk AML with Complex, Monosomal Karyotype: In Vivo Therapeutic Efficacy of Decitabine (DAC) in Patient-Derived Xenograft (PDX) Mouse Models

Gabriele Greve, PhD, Julia Schüler, DVM, Eva Oswald, PhD, Michael Lübbert
Journal: Blood
Blood (2019) 134 (Supplement_1): 2644.
https://doi.org/10.1182/blood-2019-126514
Published: 2019
Journal Articles

Urine Proteomic Analysis Reveals Disease-Specific Patterns in Pediatric Patients with Classical Hodgkin's Disease(HD). an Addon Study to the Euronet-PHL-C2 Trial

Karl-Walter Sykora, MD, Jochen Metzger, PhD, Dieter Körholz, MD PhD, Michael Frühwald, MD, Gabriele Strauss, MD, Norbert Jorch, MD, Jozef Zlocha, MD PhD, Thomas Wiesel, MD, Axel Sauerbrey, MD, Monika Streiter, MD, Rhoikos Furtwaengler, MD, Gunnar Cario, MD PhD, Thorsten Simon, MD PhD, Holger Christiansen, MD, Peter Vorwerk, MD, Angela Wawer, MD, Wolfram Scheurlen, MD, Hermann Müller, MD, Stefan Bielack, MD, Martin Ebinger, PD Dr. MD, Klaus-Michael Debatin, MD, Oliver Andres, MD, Christine Mauz-Körholz, Anja Troeger, MD, Dominik Schneider, MD, Eva M Weissinger, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2804.
https://doi.org/10.1182/blood-2019-125611
Published: 2019
Journal Articles

Brentuximab Vedotin As Consolidation Therapy Post Hematopoietic Stem Cell Transplantation for Patients with Relapsed or Refractory Hodgkin Lymphoma: A Real World Analysis of the Colombian Experience

Bonell Patiño, MD, Cristina Acon-Solano, MD, Mario Pereira, MD, Leonardo Enciso-Olivera, MD, Diana Otero-de la Hoz, MD, Humberto Martínez Cordero, MD, Paola Spirko, MD, Julio Solano-Vega, MD, Mónica Arévalo-Zambrano, MD, Ulrike Heider, MD, Alejandro Ruiz-Patiño, MD, Claudia Lucia Sossa, MD, Angela María Peña, MD, Claudia Marcela Chalela, MD, Amado Karduss, MD, Guillermo León-Basantes, MD, Virginia Abello, MD, Daniel Lorenzo Espinosa, MD, Paola Guerrero, MD, Alvaro Guerrero, MD, Juan Manuel Herrera, MD, Monica Osuna, MD, Ivan Perdomo, MD, Carmen Rosales, MD, Paola Omaña, MD, Natalia Villarroya, MD, Víctor Rodriguez-Sanjuan, MD, Jose Sandoval-Sus, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5275.
https://doi.org/10.1182/blood-2019-129295
Published: 2019
Journal Articles

AVM0703, a New Treatment Option for Lymphoma Patients

Theresa Deisher, PhD, Margaret Taylor, Arya Ashok, PhD, Peter Jarzyna, PhD, Yumna Zahid, Stephanie Lee-Diaz, Colleen Rylatt, Kendra Poulin, Vaishnavi Parthasarathy
Journal: Blood
Blood (2019) 134 (Supplement_1): 5308.
https://doi.org/10.1182/blood-2019-128812
Published: 2019
Journal Articles

Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory t[11;14] Multiple Myeloma

Diana Basali, MD, Rajshekhar Chakraborty, MD, Lisa Rybicki, MS, Nathaniel Rosko, PharmD, Janice Reed, RN, Mary Ann Karam, RN, Kristen Schlueter, RN, Hayley Dysert, Beth M. Faiman, PhDCNP, Kimberly Hamilton, APRN/PA, Matt Kalaycio, MD, Jason Valent, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5566.
https://doi.org/10.1182/blood-2019-129002
Published: 2019
Journal Articles

Itolizumab As a Potential Therapeutic for the Prevention and Treatment of Graft Vs Host Disease

Cherie Tracy Ng, PhD MPH, Jeanette Ampudia, BSc, Robert J. Soiffer, MD, Jerome Ritz, MD, Stephen Connelly, PhD MBA
Journal: Blood
Blood (2019) 134 (Supplement_1): 5603.
https://doi.org/10.1182/blood-2019-122787
Published: 2019
Journal Articles

Development of an Easily Accessible Patient-Derived Xenograft (PDX) Mouse Model in Multiple Myeloma

Can Li, MD, Yogesh Jethava, MBBS, MDFRCPath, MRCP, Ivana Frech, DSc, PhD MBA, Fenghuang Zhan, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5538.
https://doi.org/10.1182/blood-2019-121933
Published: 2019
Journal Articles

Panobinostat (LBH589) in Combination with the β-Catenin Inhibitor Tegavivint (BC2059) Exerts Significant Anti-Myeloma Activity Both in Vitro and In Vivo

Ioanna Savvidou, MD, Tiffany Khong, BSc, PhD, Sophie Whish, Tara Sepehrizadeh, Sridurga Mithraprabhu, PhD MSc, Michael DeVeer, BSc, PhD, Andrew Spencer, DM
Journal: Blood
Blood (2019) 134 (Supplement_1): 5540.
https://doi.org/10.1182/blood-2019-126468
Published: 2019
Journal Articles

Impact of Disease Burden in Myelofibrosis Patients: A Sub Analysis from Italian Romei Observational Study

Francesca Palandri, PhD MD, Massimo Breccia, MD, Carmine Selleri, MD, Francesco Mendicino, MD, Giuseppe A. Palumbo, MD PhD, Elisabetta Abruzzese, MD, Anna Marina Liberati, Nicola Di Renzo, MD, Fabrizio Pane, MD, Mario Tiribelli, Robin Foà, MD, Elena Maria Elli, MD, Giovanni Caocci, MD, Mara Morelli, MD, Paola Guglielmelli, MD PhD, Francesco Passamonti, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4188.
https://doi.org/10.1182/blood-2019-125778
Published: 2019
Journal Articles

A Retrospective Real-World Study of the Current Treatment Pathways for Myelofibrosis in the UK (The REALISM UK Study)

Adam J. Mead, MD PhD, Tim Somervaille, Professor, MD, Nauman M Butt, MD, Waseem Nagi, MD FRCPath, Alastair J Whiteway, MBBS, Suriya Kirkpatrick, MD, Ciro R Rinaldi, MD PhD, Catherine Roughley, MD, Sam Ackroyd, MD, Joanne Ewing, PhDBMBS BSc FRPATH, Pratap Neelakantan, MD FRCPath, Mamta Garg, MD FRCP, FRCPath, Claire N Harrison, Professor, David Tucker, MD, Rozinder Bains, Gavin Chiu, MBBS, MRCGP, MFPM, DPM, BSc, Joe Hickey, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1671.
https://doi.org/10.1182/blood-2019-124686
Published: 2019
Journal Articles

Metformin Suppress Cellular and Molecular Processes Related to Maintenance and Proliferation of Myeloproliferative Neoplasm Stem Cell

Juan L Coelho-Silva, BSc, MSc, Thiago Mantello Bianco, MSc, Antonio Bruno Alves Silva, BSc, Diego Antonio Pereira-Martins, M.Sc., Natasha Peixoto Fonseca, B.Sc., M.Sc., Isabel Weinhäuser, MSc, Eduardo M Rego, MD PhD, Fernando Chahud, MD PhD, João Agostinho Machado-Neto, PhD, Lorena Lobo Figueiredo-Pontes, MD PhD, Fabiola Traina, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1682.
https://doi.org/10.1182/blood-2019-132115
Published: 2019
Journal Articles

Anti-Bcma PBD MEDI2228 Combats Drug Resistance and Synergizes with Bortezomib and Inhibitors to DNA Damage Response in Multiple Myeloma

Lijie Xing, MD, Liang Lin, PhD, Tengteng Yu, MD PhD, Yuyin Li, PhD, Kenneth Wen, BS, Shih-Feng Cho, MD PhD, Phillip A Hsieh, Krista Kinneer, Nikhil C. Munshi, MD, Kenneth C. Anderson, MD, Yu-Tzu Tai, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1817.
https://doi.org/10.1182/blood-2019-127163
Published: 2019
Journal Articles

Patient-Reported Outcomes (PRO) Data from Patients (Pts) with Essential Thrombocythemia (ET) Enrolled in the MOST Study

Ellen K. Ritchie, MD, Anas Al-Janadi, MD, Philomena Colucci, DO, MS, Patricia Kalafut, PhD, Dilan Paranagama, PhD, Ruben A. Mesa, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1665.
https://doi.org/10.1182/blood-2019-124527
Published: 2019